Aflac stock holds firm after mixed August 6 results
Published on 08/25/2026 at 09:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Aflac Inc. (US0010551028) stock is trading near a $116.62 consensus target after the insurer reported $4.22 billion in revenue and $1.75 in earnings per share for the quarter ended August 6, 2026.
The latest quarter also showed revenue down 1.0% year over year and EPS lower than the $1.76 consensus by $0.01, a small miss that keeps the valuation debate centered on execution rather than scale.
Results stayed mixed
Recent coverage of the results says the company delivered revenue above the $4.11 billion estimate, but the bottom line did not fully match expectations. That split helped keep the average price target at $116.62 while sentiment stayed at Hold.
For investors, the key comparison is simple: $4.22 billion in revenue versus $4.11 billion expected, and $1.75 EPS versus $1.76 expected. The gap is narrow, but it is large enough to matter for a stock that already trades close to consensus.
What analysts are saying
Sell-side models currently point to full-year EPS of 7.04, which puts the latest quarter into a broader earnings framework rather than a one-off print. That forecast also leaves room for the next results to shift the debate if margins or investment income improve.
A recent market summary put the stock at $117.77 during intraday trading on August 24, 2026, with a day range of $117.14 to $118.22 and a 52-week range of $104.66 to $130.22.
The dividend angle
A separate filing summary said shareholders of record on August 19, 2026, will receive a $0.61 quarterly dividend on September 1, 2026. At an annualized $2.44 per share, the payout remains a major part of the stock's appeal.
That income profile matters because the shares are still sitting between the 52-week low of $104.66 and the 52-week high of $130.22, leaving the market to weigh stability against limited near-term upside.
Aflac's core business
Aflac's main products remain supplemental accident and health insurance, with premiums and policy volumes driving the earnings base. The most recent quarter showed that business can still produce top-line growth even when profit momentum is less consistent.
Price and market view
As of August 24, 2026, Aflac stock was changing hands at $117.77 in real-time trading on the NYSE, and the market capitalization was about $63.6 billion. The stock remains close to the consensus target of $116.62, so the next move will likely depend on whether upcoming results can turn that narrow revenue beat into a cleaner earnings beat.
Company
Company: Aflac Inc.
ISIN: US0010551028
Ticker: AFL
Exchange: NYSE
Price (as of August 24, 2026, 1:50 p.m. ET): $117.77 USD
Market cap: $63.6 billion
Sector / Industry: Financials / Insurance - Life & Health
Index membership: S&P 500
Next earnings date: November 4, 2026
